Efficacy of a plant-produced infectious bronchitis virus-like particle vaccine in specific pathogen-free chickens

• Published in: Poultry science Vol. 102; no. 10; p. 102953
• Main Authors: Sepotokele, Kamogelo M., O'Kennedy, Martha M., Hayes, Michaela C., Wandrag, Daniel B.R., Smith, Peter, Abolnik, Celia
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01-10-2023; Elsevier
• Subjects: IMMUNOLOGY, HEALTH AND DISEASE; infectious bronchitis; N. benthamiana; vaccine; virus-like particle; infectious bronchitis; vaccine; virus-like particle; N. benthamiana
• ISSN: 0032-5791; 1525-3171
• DOI: 10.1016/j.psj.2023.102953

Infectious bronchitis (IB) Gammacoronavirus causes a highly contagious respiratory disease in chickens that is listed by the World Organisation for Animal Health (WOAH). Its high mutation ability has resulted in numerous variants against which the commercially available live or recombinant vaccines singly offer limited protection. Agrobacterium-mediated transient expression in Nicotiana benthamiana (tobacco) plants was used here to produce a virus-like particle (VLP) vaccine expressing a modified full-length IBV spike (S) protein of a QX-like IB variant. In a challenge study with the homologous live IB QX-like virus, VLP-vaccinated birds produced S protein-specific antibodies comparable to those produced by live-vaccinated birds seroconverting with mean geometric titers of 6.8 and 7.2 log2, respectively. The VLP-vaccinated birds had reduced oropharyngeal and cloacal viral shedding compared to an unvaccinated challenged control and were more protected against tracheal ciliostasis than the live-vaccinated birds. While the results appeared similar, plant-produced IB VLPs are safer, more affordable, easier to produce and update to antigenically match any emerging IB variant, making them a more suitable alternative to IBV control than live-attenuated vaccines.